| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Doyle Mittie Chief Medical Officer | Sale | -679 | -1.42%47,122 | $16.00 | $10,864 | View SEC filing | |
| 2026-05-19 | Doyle Mittie Chief Medical Officer | Sale | -3,000 | -45.30%3,622 | $18.76 | $56,280 | View SEC filing | |
| 2026-05-11 | Sullivan Christopher Ryan Chief Financial Officer | Sale | -18,606 | -97.78%423 | $24.12 | $448,818 | View SEC filing | |
| 2026-05-07 | Doyle Mittie Chief Medical Officer | Sale | -108,234 | -31.67%3,622 | $20.61 | $2,230,367 | View SEC filing | |
| 2026-05-07 | Sullivan Christopher Ryan Chief Financial Officer | Sale | -47,000 | -99.11%423 | $20.19 | $948,722 | View SEC filing | |
| 2026-05-07 | Chan Mitchell Director | Sale | -3,167 | -50.01%3,166 | $22.88 | $72,461 | View SEC filing | |
| 2026-05-07 | VARKI PAUL Chief Legal Officer | Sale | -75,063 | -95.38%3,634 | $20.17 | $1,513,673 | View SEC filing | |
| 2026-05-01 | Sullivan Christopher Ryan Chief Financial Officer | Sale | -16,915 | -97.56%423 | $13.16 | $222,589 | View SEC filing | |
| 2026-04-08 | Doyle Mittie Chief Medical Officer | Sale | -3,970 | -52.29%3,622 | $18.01 | $71,508 | View SEC filing | |
| 2026-04-03 | Doyle Mittie Chief Medical Officer | Sale | -679 | -15.79%3,622 | $16.00 | $10,864 | View SEC filing | |
| 2026-04-03 | Sullivan Christopher Ryan Chief Financial Officer | Sale | -15,959 | -47.93%17,338 | $16.96 | $270,593 | View SEC filing | |
| 2026-03-18 | Doyle Mittie Chief Medical Officer | Sale | -25,492 | -87.56%3,622 | $16.15 | $411,607 | View SEC filing | |
| 2025-11-17 | Goldman Jonathan Director | Sale | -11,367 | -100.00%0 | $14.33 | $162,937 | View SEC filing | |
| 2024-11-14 | Almenoff June Sherie Director | Purchase | +1,000 | +100.00%1,000 | $12.75 | $12,750 | View SEC filing | |
| 2023-06-28 | ARMISTICE CAPITAL, LLC 10% Owner | Sale | -3,683,542 | -83.43%731,458 | $0.59 | $2,168,897 | View SEC filing | |
| 2023-06-27 | Caissa Capital Management ltd. 10% Owner | Purchase | -1,608,000 | -100.00%0 | $0.64 | $1,030,179 | View SEC filing | |
| 2023-06-20 | Caissa Capital Management ltd. 10% Owner | Purchase | +8,160 | +0.58%1,425,700 | $3.88 | $31,644 | View SEC filing | |
| 2023-06-14 | Caissa Capital Management ltd. 10% Owner | Purchase | +16,899 | +1.21%1,417,540 | $3.77 | $63,629 | View SEC filing | |
| 2023-06-13 | Sullivan Christopher Ryan Chief Financial Officer | Purchase | +511 | +68.04%1,262 | $3.42 | $1,748 | View SEC filing | |
| 2023-06-13 | NEIL GARRY ARTHUR CEO and Chairman of the Board | Purchase | +4,000 | +43.38%13,220 | $3.42 | $13,680 | View SEC filing | |
| 2023-06-09 | Caissa Capital Management ltd. 10% Owner | Purchase | +14,426 | +1.04%1,400,641 | $3.91 | $56,440 | View SEC filing | |
| 2023-06-02 | Caissa Capital Management ltd. 10% Owner | Purchase | +844 | +0.06%1,386,215 | $2.87 | $2,422 | View SEC filing | |
| 2023-05-30 | Caissa Capital Management ltd. 10% Owner | Purchase | +2,671 | +0.19%1,385,371 | $2.79 | $7,464 | View SEC filing | |
| 2023-05-24 | Caissa Capital Management ltd. 10% Owner | Purchase | +9,000 | +0.66%1,382,700 | $2.98 | $26,816 | View SEC filing | |
| 2023-05-22 | Caissa Capital Management ltd. 10% Owner | Purchase | +26,621 | +1.98%1,373,700 | $3.36 | $89,372 | View SEC filing |
1-25 of 137
